These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 17625931)
1. Matrix metalloproteinases at cancer tumor-host interface. Noël A; Jost M; Maquoi E Semin Cell Dev Biol; 2008 Feb; 19(1):52-60. PubMed ID: 17625931 [TBL] [Abstract][Full Text] [Related]
2. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Jodele S; Blavier L; Yoon JM; DeClerck YA Cancer Metastasis Rev; 2006 Mar; 25(1):35-43. PubMed ID: 16680570 [TBL] [Abstract][Full Text] [Related]
3. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis]. Masson V Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905 [TBL] [Abstract][Full Text] [Related]
4. [Breast cancer invasion: the key role of normal cells of host tissues]. Foidart JM; Polette M; Birembaut P; Noel A Bull Acad Natl Med; 1994 Mar; 178(3):533-42; discussion 542-4. PubMed ID: 8076190 [TBL] [Abstract][Full Text] [Related]
6. Tumour invasion and matrix metalloproteinases. Polette M; Nawrocki-Raby B; Gilles C; Clavel C; Birembaut P Crit Rev Oncol Hematol; 2004 Mar; 49(3):179-86. PubMed ID: 15036258 [TBL] [Abstract][Full Text] [Related]
7. MT1-MMP: universal or particular player in angiogenesis? Genís L; Gálvez BG; Gonzalo P; Arroyo AG Cancer Metastasis Rev; 2006 Mar; 25(1):77-86. PubMed ID: 16680574 [TBL] [Abstract][Full Text] [Related]
8. Three matrix metalloproteinases are required in vivo for macrophage migration during embryonic development. Tomlinson ML; Garcia-Morales C; Abu-Elmagd M; Wheeler GN Mech Dev; 2008; 125(11-12):1059-70. PubMed ID: 18684398 [TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Etoh T; Inoue H; Tanaka S; Barnard GF; Kitano S; Mori M Cancer Res; 2001 Mar; 61(5):2145-53. PubMed ID: 11280779 [TBL] [Abstract][Full Text] [Related]
10. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Zucker S; Cao J; Chen WT Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650 [TBL] [Abstract][Full Text] [Related]
11. Metalloproteinases in tumor progression: the contribution of MMP-9. Himelstein BP; Canete-Soler R; Bernhard EJ; Dilks DW; Muschel RJ Invasion Metastasis; 1994-1995; 14(1-6):246-58. PubMed ID: 7657517 [TBL] [Abstract][Full Text] [Related]
12. Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis. Forget MA; Desrosiers RR; Béliveau R Can J Physiol Pharmacol; 1999 Jul; 77(7):465-80. PubMed ID: 10535707 [TBL] [Abstract][Full Text] [Related]
13. [Roles of matrix metalloproteinases and tissue inhibitor of metalloproteinase (TIMP) in cancer invasion and metastasis]. Okada A Gan To Kagaku Ryoho; 1999 Dec; 26(14):2247-52. PubMed ID: 10635313 [TBL] [Abstract][Full Text] [Related]